[Federal Register: April 26, 1999 (Volume 64, Number 79)]
[Notices]               
[Page 20315-20316]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26ap99-121]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Advisory Council on Drug Abuse.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal property.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: May 25, 1999.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Neuroscience Center, National Institutes of Health, 6001 
Executive Blvd., Bethesda, MD 20892.
    Contact Person: Teresa Levitin, Director, Office of Extramural 
Program Review, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, Bethesda, MD 20892-9547, (301) 443-2755.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist

[[Page 20316]]

Development Award for Clinicians, Scientist Development Awards, and 
Research Scientist Awards; 93.278, Drug Abuse National Research 
Service Awards for Research Training; 93.279, Drug Abuse Research 
Programs, National Institutes of Health, HHS)

    Dated: April 16, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-10367 Filed 4-23-99; 8:45 am]
BILLING CODE 4140-01-M